View post: Chi-Med Announces the NMPA Approval of Surufatinib (Sulanda® in China) for Non-Pancreatic Neuroendocrine Tumors
View post: Chi-Med Announces the NMPA Approval of Surufatinib (Sulanda® in China) for Non-Pancreatic Neuroendocrine Tumors
Read the rest here: Cyclacel Pharmaceuticals to Present at Biotech Showcase™ Digital 2021
Continued here: Altimmune Begins Multinational Phase 2 Clinical Trial of HepTcellTM, a Novel Immunotherapeutic for the Treatment of Chronic Hepatitis B
See the original post here: TRACON Pharmaceuticals Announces Acceptance of the Envafolimab (KN035) NDA by the NMPA in China that was Submitted by its Corporate Partners Alphamab...
Read more here: Morphic Therapeutic to Present at the Virtual 39th Annual J.P. Morgan Healthcare Conference
Read the original post: BioCardia Issued New U.S. Patent for Technology that Enhances Control for Cardiac Therapies
See the rest here: Ocuphire to Present at the LifeSci Partners 10th Annual Healthcare Corporate Access Event in Early January 2021
Here is the original post: Orphazyme provides regulatory update on arimoclomol for NPC
View post: Better Choice to Begin Trading on the OTCQX
More: Cara Therapeutics Submits New Drug Application to U.S. Food and Drug Administration for KORSUVA™ Injection in Hemodialysis Patients with...
Recent Comments